Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2026)
Rigel Pharmaceuticals' quarterly Inventory Average came in at $11.6 million in Q1 2026, up 117.22% year-on-year from $5.3 million in Q1 2025, and down 6.65% quarter-over-quarter from $12.4 million in Q4 2025.
Rigel Pharmaceuticals has reported Inventory Average for 9 years, with the latest figure at $11.6 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 117.22% year-over-year to $11.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (up 117.22% YoY), and the FY2025 full-year result was $8.8 million, up 51.93% from the prior year.
- Inventory Average for Q1 2026 stood at $11.6 million, down from $12.4 million in the prior quarter.
- The five-year high for Inventory Average was $12.4 million in Q4 2025, with the low at $5.3 million in Q1 2025.
- Average Inventory Average over 5 years is $8.1 million, with a median of $7.3 million recorded in 2024.
- Year-over-year, Inventory Average tumbled 40.08% in 2024 and soared 130.01% in 2025.
- Tracing RIGL's Inventory Average over 5 years: stood at $8.1 million in 2022, then decreased by 28.34% to $5.8 million in 2023, then slipped by 7.29% to $5.4 million in 2024, then soared by 130.01% to $12.4 million in 2025, then declined by 6.65% to $11.6 million in 2026.
- The last three Inventory Average figures came in at $11.6 million (Q1 2026), $12.4 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 11.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.58 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | 11.86 Mn |
| Jun 30, 2025 | 7.54 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 10.93 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 8.12 Mn |
| Sep 30, 2022 | 6.67 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2021 | 6.93 Mn |
| Jun 30, 2021 | 6.89 Mn |
| Mar 31, 2021 | 4.29 Mn |
| Dec 31, 2020 | 1.84 Mn |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 1.65 Mn |
| Mar 31, 2020 | 1.49 Mn |
| Dec 31, 2019 | 1.27 Mn |
| Sep 30, 2019 | 1.20 Mn |
| Jun 30, 2019 | 1.18 Mn |
| Mar 31, 2019 | 1.01 Mn |
| Dec 31, 2018 | 714,000.00 |
| Sep 30, 2018 | 514,000.00 |